LRT Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-383
Closed -$412K 108
2025
Q4
$412K Sell
383
-478
-56% -$457K 0.35% 74
2025
Q3
$657K Buy
+861
New +$641K 0.44% 68
2024
Q4
Sell
-1,163
Closed -$1.03M 103
2024
Q3
$1.03M Buy
1,163
+510
+78% +$459K 0.96% 45
2024
Q2
$591K Sell
653
-297
-31% -$238K 0.56% 59
2024
Q1
$739K Buy
950
+35
+4% +$24.9K 0.66% 55
2023
Q4
$533K Buy
+915
New +$534K 0.5% 66

Other funds holding LLY

LRT Capital Management's LLY Position: Q1 2026 in Review

LRT Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 383 shares — an estimated $412K sold.

LRT Capital Management first reported a position in LLY in Q4 2023 and held it in 6 quarters. The position peaked at $1.03M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • LRT Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • LRT Capital Management sold 383 Eli Lilly shares in Q1 2026, an estimated $412K.
  • LRT Capital Management first reported a position in Eli Lilly in Q4 2023 and held it in 6 quarters.
  • LRT Capital Management's Eli Lilly position peaked at $1.03M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on LRT Capital Management's 13F filing for Q1 2026, filed 15 May 2026.